Rebecca M. Shulman, MD

Rebecca Shulman Resize v2
This physician is not currently rated. Why?

Why is this doctor not rated?


To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings

Assistant Professor, Radiation Oncology


  • Radiation Oncology
  • Sarcoma and Connective Tissue Radiation Oncology
  • Breast Radiation Oncology

Areas of Expertise

Breast Cancer, Sarcoma

Treatment Focus

Stereotactic Body Radiation Therapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Hypofractionated Radiation Therapy, Ultra Hypofractionated Radiation Therapy, Re-irradiation, Brachytherapy, Oligometastatic treatment

Language(s) Other than English

  • Spanish

Treatment Philosophy

The practice of radiation oncology requires more than designating a preset course of treatment for some well-defined diagnosis. The need for an individualized approach, the requirement that our patients agree to a treatment plan that may take weeks to complete, the obligation to set realistic and particularized goals, all of these mean that the relationship between physician and patient must assume the form of a partnership. The basis of any partnership is trust, which for a true partnership must be earned. I strive to earn the trust of my patients by offering them the benefits of cutting-edge technology, and no less importantly, by offering an attentive ear and unwavering emotional support. I am guided by the belief that my personal success can be measured by the capacity of my patients to take on the challenges of a serious illness with faith in their own strength and resilience. 

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Educational Background

  • 2021-2022 Chief Resident, Fox Chase Cancer Center, Philadelphia, PA 19111
  • 2019-2023 Resident, Fox Chase Cancer Center, Philadelphia, PA 19111
  • 2018-2019 Intern, Crozer Chester Medical Center, Chester, PA 19013
  • 2014-2018 MD, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140
  • 2009-2013 BA, Psychology, New York University, New York, NY 10012


  • American Society of Therapeutic Radiology (ASTRO)
  • American Society of Clinical Oncology (ASCO)
  • Radiological Society of North America (RSNA) 


Honors & Awards

  • 2023-2025 Robert A. Winn Diversity in Clinical Trials: Career Development Award. “NRG BR007: A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-negative, Oncotype Recurrence Score ≤ 18 Breast Cancer (DEBRA)”
  • 2023-2024 ASTRO-BCRF Emerging Investigator Award. “Combination therapy with radiotherapy, immune checkpoint blockade, and curaxin enhances tumor regression in metastatic triple-negative breast cancer”
  • 2022-2024 LUNGevity Health Equity and Inclusiveness Research Fellow Award. “Synergistic expression of combined RT and dual-immune checkpoint blockade” 
  • 2021-2022 Conquer Cancer Foundation ASCO Young Investigator Award. “Genotyping of BRCA1 mutations predicts radio sensitivity in breast cancers and in cultured breast cancer cells.”  
  • 2021-2022 In Vino Vita Young Investigator Award. “Genotyping of BRCA1 mutations predicts radio sensitivity in breast cancers and in cultured breast cancer cells.” 
  • 2022 RSNA Roentgen Resident/Fellow Research Award
  • 2022 ECOG-ACRIN Group Meeting Spring 2022 Travel Grant
  • 2021-2022 AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowship
  • 2022 Alpha Omega Alpha Honor Society
  • 2020 Harvard Macy Program for Postgraduate Trainees: Future Academic Clinician Educators
  • 2017 Gold Humanism Honor Society
  • 2016 Conwell Scholar Award
  • 2016 American Balint Essay Contest Winner
  • 2016 Tractenberg Ethics Essay Contest Finalist
  • 2015 Conwell Scholar Award
  • 2014 Conwell Scholar Award

Research Interests

Combining biological discoveries, including our expanding knowledge of inflammatory and immune cellular mechanisms, with the innovative techniques of precision radiotherapy to devise effective cancer treatments

Selected Publications


1.    Shulman RM, Weinberg DS, Ross EA, et al. Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine. J Natl Compr Canc Netw. 2022;20(2):160-166. doi:10.6004/jnccn.2021.7113. PubMed PMID: 35130494
2.    Shulman RM, Meyer JE. Current Trends in the Treatment of Locally Advanced Rectal Cancer: Where We Are and How We Got Here. Curr Colorectal Cancer Rep 17, 88–102 (2021).
3.    Shulman RM, Galloway TJ. A Hard Case to Swallow: Multiple Primary Cancers With Multiple Possible Answers in the Setting of Solid Organ Transplantation. International Journal of Radiation Oncology*Biology*Physics. 2022;112(3):584-585. doi:10.1016/j.ijrobp.2021.11.004
4.    Shulman RM, Meyer JM. Current Trends in the Treatment of Locally Advanced Rectal Cancer. ASCO Daily News, January 2021. 
5.    Shulman RM, Meyer JE. Patterns of Failure and Need for Biliary Intervention in Resected Biliary Tract Cancers after Chemoradiation. Ann Surg Oncol. 2020. PMID: 32804323.
6.    Shulman RM, Meyer JE, Li T, Howell KJ. External beam radiation therapy (EBRT) for asymptomatic bone metastases in patients with solid tumors reduces the risk of skeletal-related events (SREs). Ann Palliat Med. 2019 Apr;8(2):159-67. PMID: 30525770.
7.    Shulman RM. and Abbas, A.E. The state of the art and future directions of robotic-assisted thoracic surgery. Ind J Thorac Cardiovasc Surg. 2018; 34: 40–46.

Additional Publications

1.    Shulman RM. The Basest of the Senses: Medical Unease with the Sense of Smell. Hektoen International Journal. Volume 10, Issue 2 – 2018 Spring.
2.    Shulman RM. Colorblindness and Its Illuminations. Pharos Journal of the Alpha Omega Alpha Honor Med Soc. 2017 Autumn. 
3.    Bell K., Yohay Bloom Y, Carlaw K, Dascanio G, Ebrahim A., Gipperich A, Hamilton E, Huntington G, Ly J, Mayo E, Rotem-Green M, Shulman RM, Stosik D, Tinawi G, Vinegrad N. (2017). Acquiring Clinical Modesty. In H. Otten, G. Bergmann, D. Nease (Ed.), The Student, the Patient, and the Illness: Ascona Balint Award Essays 2017 (pp. 150-157). Hamburg: Psychosozial Verlag.
4.    Shulman RM. (2018). Acquiring clinical modesty. The International Journal of Psychiatry in Medicine, 53(1–2), 92–97. 

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...